New England Tech Stock Index

Nexage moves in, Oscient files for bankruptcy and Delfigo partners with Children’s Hospital in today’s Finance Roundup. 

• Oscient faces de-listing, files Ch. 11, sells Factive drug

Drug maker Oscient Pharmaceuticals Corp. filed for Chapter 11 bankruptcy protection yesterday, along with its wholly owned subsidiary, Guardian II Acquisition Corp. At the same time, Oscient is selling one of its two drugs, Factive, for more than $5 million.

• Nexage raises $4M, plans move to Boston

 

California mobile advertising firm Nexage Inc. said it closed a first round of funding with $4 million and will move its headquarters from Fremont to Boston.

Nexage said the funding came from Wellesley-based GrandBanks Capital and BlackBerry Partners Fund of Canada.

• Delfigo launches security product, signs deal with Children’s Hospital

Delfigo Corp., a Boston developer of authentication software, announced Tuesday the launch of its first product, DSGateway, and the signing of Children’s Hospital Boston as its first customer. (more…)